why choose us

First received: March 08, 2023

Clinical Trial: 18F-LY3950321-01 Biodistribution and Safety Study

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Diagnostic Agent Adverse Reaction

Study Type: INTERVENTIONAL


Official Title: A Phase 1, Open-label Study to Evaluate the Biodistribution and Safety of 18F-LY3950321 (18F-MNI-1256) in Healthy Subjects

Brief Summary: 18F-LY3950321 (also known as 18F-MNI-1256) is a radiolabeled positron emission tomography (PET) tracer targeting granzyme B. The overall goal of this protocol is to evaluate the safety, tolerability, and radiation dosimetry of 18F-LY3950321.

Read more